Biotech Business - February 9, 2024
Alligator Bioscience restructures
The company plans to restructure and reduce its workforce by 20-25%, with expected annual costs savings of SEK 20 million. “Over the last 12 months our OPTIMIZE-1 trial evaluating our lead asset mitazalimab in pancreatic cancer has delivered two sets of highly encouraging interim data as well as faster-than-expected patient recruitment leading to an accelerated […]
Biotech Business - February 7, 2024
Abera conducts a directed share issue of SEK 4 million
In connection with the company’s decision to develop a nasal vaccine candidate for influenza, based on recent progress with its mucosal vaccine platform, the board of Abera has decided to conduct a directed new share issue. Abera’s platform enables mucosal immunization, such as through nasal spray, which can inhibit the growth of viruses and bacteria […]
Agreement - February 5, 2024
Biovian and 3P Biopharmaceuticals join forces
The two biologics Contract Development and Manufacturing Organizations (CDMOs), have announced their combination. Backed by their common shareholder, Keensight Capital, the combination of Biovian and 3P extends the group’s value proposition to address complex customer needs across the entire development cycle, the companies state. Keensight Capital will continue to help the Group strengthen its position […]
Business Award - January 31, 2024
Genovis wins SwedenBIO Award
Genovis’ CEO, Fredrik Olsson, received the award in a prize ceremony during SwedenBIO Summit at Grand Hôtel in Stockholm on 30th January. High-quality research, global presence and humor were some of the positive words describing the company Genovis, which claimed this year’s SwedenBIO Award. “Life science is a tough industry where success doesn’t come easy, […]
Business article - January 30, 2024
SwedenBIO’s Life Science Barometer has been released
The Life Science Barometer is an annual survey with the aim of offering unique insights and fresh statistics about the Swedish life science industry. A record number of companies participated in the survey for this year’s edition, which makes the report SwedenBIO’s most comprehensive to date. The report is produced by SwedenBIO in collaboration with […]
Biotech Business - January 25, 2024
Nykode has onboarded US based CapitalGroup as investors
In October 2023, Nykode completed a private placement round of approx NOK 505 million and this week, the company revealed that CapitalGroup, one of the world’s ten largest capital management funds, represented ca 40% of the financing round. This places CapitalGroup as the company’s sixth largest investor. Read more: Nykode Therapeutics raises NOK 505 million […]
